{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:29:33Z","timestamp":1758634173362},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.transproceed.2018.03.027","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T23:47:33Z","timestamp":1521157653000},"page":"1842-1846","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management of Renin-Angiotensin-Aldosterone System Blockade in Kidney Transplant Recipients"],"prefix":"10.1016","volume":"50","author":[{"given":"Z.","family":"Heleniak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Ku\u017amiuk-Glembin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Adrych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wi\u015bniewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tylicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"D\u0119bska-\u015alizie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.03.027_bib1","first-page":"900","article-title":"Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions","volume":"25","author":"Tylicki","year":"2012","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.027_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00042307-200303000-00002","article-title":"Treatment of hypertension in renal transplant recipients","volume":"13","author":"Tylicki","year":"2003","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.transproceed.2018.03.027_bib3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2014080834","article-title":"Assessment and management of hypertension in transplant patients","volume":"26","author":"Weir","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.027_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation","volume":"17","author":"Heinze","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.027_bib5","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report","volume":"17","author":"Opelz","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.027_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-6143.2006.01588.x","article-title":"Renal allograft protection with angiotensin II type 1 receptor antagonists","volume":"7","author":"Tylicki","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.027_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/gfp581","article-title":"Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET","volume":"25","author":"Philipp","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2018.03.027_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ki.2012.425","article-title":"Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?","volume":"83","author":"Wheeler","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2018.03.027_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08037051.2014.986931","article-title":"Treatment of hypertension in chronic kidney disease patients under specialized care: one-center cross-sectional analyses","volume":"24","author":"Tylicki","year":"2015","journal-title":"Blood Press"},{"key":"10.1016\/j.transproceed.2018.03.027_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0272-6386(00)70302-7","article-title":"ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy","volume":"35","author":"Stigant","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2018.03.027_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.tp.0000188137.50178.7d","article-title":"Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients","volume":"81","author":"Tylicki","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.03.027_bib12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/01.HYP.26.3.436","article-title":"Comparison of perindopril and amlodipine in cyclosporine-treated renal allograft recipients","volume":"26","author":"Sennesael","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.transproceed.2018.03.027_bib13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1046\/j.1523-1755.2000.00926.x","article-title":"Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat","volume":"57","author":"Szabo","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2018.03.027_bib14","first-page":"31","article-title":"Antihypertensive treatment in renal transplant patients\u2014is there a role for ACE inhibitors?","volume":"6","author":"Hausberg","year":"2001","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2018.03.027_bib15","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/ndt\/gfm864","article-title":"ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations","volume":"23","author":"Mitterbauer","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2018.03.027_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/ndt\/5.11.969","article-title":"Erythrocytosis after renal transplantation; treatment by removal of the native kidneys","volume":"5","author":"Friman","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2018.03.027_bib17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ki.1983.86","article-title":"Postrenal transplant erythrocytosis: a review of 53 patients","volume":"23","author":"Wickre","year":"1983","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2018.03.027_bib18","first-page":"176","article-title":"Cardiovascular disease after renal transplantation","volume":"20","author":"Kasiske","year":"2000","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.027_bib19","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1016\/j.transproceed.2009.07.090","article-title":"Anemia and erythrocytosis after kidney transplantation: a 5-year graft function and survival analysis","volume":"41","author":"Kolonko","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.03.027_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1432-2277.2012.01513.x","article-title":"Anemia and erythrocytosis in patients after kidney transplantation","volume":"25","author":"Malyszko","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2018.03.027_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(05)78150-2","article-title":"Losartan and renal transplantation","volume":"351","author":"Horn","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2018.03.027_bib22","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(05)60660-5","article-title":"Losartan and renal transplantation","volume":"351","author":"Aurup","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2018.03.027_bib23","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/TP.0000000000000938","article-title":"The association between renin-angiotensin system blockade and long-term outcomes in renal transplant recipients: the Wisconsin Allograft Recipient Database (WisARD)","volume":"100","author":"Shin","year":"2016","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518303452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518303452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T07:18:27Z","timestamp":1532675907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518303452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0041134518303452"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.03.027","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Renin-Angiotensin-Aldosterone System Blockade in Kidney Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}